Forum for Science, Industry and Business

No compulsory genetic testing for newborn babies in Europe

European Research Commissioner Philippe Busquin today rejected stories in several media claiming he had called for genetic testing of all newborn babies in Europe. Mr Busquin said: “I have never advocated any such point of view. It is not the role nor the intention of the Commission to ask EU Member States to impose universal genetic screening of babies. Genetic testing is a matter of free choice and of ethical rules being decided by EU Member States. The Commission does not regulate ethics. I certainly welcome the contribution of the expert group on genetic testing which presented its report to the Commission on May 6-7, 2004. But its recommendations are simple suggestions – and they don’t call for universal genetic testing of babies! Genetic testing can certainly help in the early detection of illnesses, but can never be made compulsory. European citizens rightly expect that the results of genetic tests are reliable and that their genetic information is used properly and following strict quality and ethical standards. The Commission is in particularly studying the issue of quality and reliability of this new technology, that must be used in a responsible and voluntary way and in a climate of confidence with the public at large.”

Independent advice

On December 2002, the European Commission established an expert group to address the ethical, legal and social implications of genetic testing. The Group included representatives from NGOs (including patient organisations), pharmaceutical companies (GSK, Roche, Novartis, Bayer, Genzyme), scientists and representatives from academia specialising in law, philosophy, ethics and medicine. The Group was acting in full autonomy and independence. It prepared a report and 25 recommendations on the ethical, legal and social implications of genetic testing. They only reflect the views of the expert group’s members and are not legally binding.

Fabio Fabbi | EU Commission
Further information:
http://europa.eu.int
http://europa.eu.int/comm/research/conferences/2004/genetic/index_en.htm

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...